Clinical Trial Update: A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

This Phase 3 safety-extension trial evaluates ABT-335 in combination with statin therapy for mixed dyslipidemia; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• ABT-335

Snippet

Sponsor: Abbott | Conditions: Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2009-12-07